ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2019

Dulaglutide as an Add-on to Insulin in Type 2 Diabetes; Clinical Efficacy and Parameters Affecting the Response in Real-World Practice.

Jiwoo Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.